White label ELPA - ClinicalTrials.eu

Study on Adding Nivolumab to Cisplatin and Radiotherapy for High-Risk Patients with Head and Neck Squamous Cell Carcinoma

Not recruiting

3 1 1 1
Investigated diseases:
- Squamous cell carcinoma of head and neck
Investigated drugs:
- Cisplatin
- Nivolumab
Study of Trastuzumab Deruxtecan Treatment for Patients with Advanced Solid Tumors Having HER2 Mutations

Not recruiting

2 1 1
Investigated drugs:
- Trastuzumab Deruxtecan
Study on the Safety and Effectiveness of Terbinafine for Patients with Chronic Hepatitis B

Not recruiting

2 1 1
Investigated diseases:
- Chronic hepatitis B
Investigated drugs:
- Terbinafine
Study on the Safety and Effects of Trastuzumab Deruxtecan with Drug Combination for Patients with Metastatic HER2-low Breast Cancer

Not recruiting

1 1 1 1
Investigated drugs:
Study on Long-Term Safety and Effectiveness of Zilucoplan in Adults with Generalized Myasthenia Gravis

Not recruiting

3 1 1 1
Investigated diseases:
- Myasthenia gravis
Investigated drugs:
- ZILUCOPLAN
Study on Long-Term Safety and Effectiveness of Liposomal Ciclosporin A for Patients with Bronchiolitis Obliterans Syndrome After Lung Transplantation

Not recruiting

3 1 1
Investigated diseases:
- Obliterative bronchiolitis
Investigated drugs:
- Ciclosporin A
Study on the Effects of Etifoxine in Treating Depression in Patients with Unipolar or Bipolar Disorder

Not recruiting

2 1 1
Investigated diseases:
- Bipolar disorder
- Depression
Investigated drugs:
- Etifoxine Hydrochloride
Study of ponatinib and azacitidine combination treatment in patients with accelerated phase or blast crisis chronic myelogenous leukemia

Not recruiting

2 1 1 1
Investigated diseases:
- Chronic myeloid leukaemia
Investigated drugs:
- Ponatinib
- Azacitidine
Study of Spironolactone and Dihydralazine for reducing heart muscle scarring in patients with severe aortic valve narrowing after valve replacement procedure

Not recruiting

2 1 1 1
Investigated diseases:
- Aortic stenosis
Investigated drugs:
- Spironolactone
Study for Adults with Very High-Risk T-Cell Acute Lymphoblastic Leukemia Using Daratumumab and a Drug Combination

Not recruiting

2 1 1 1
Investigated diseases:
- T-cell type acute leukaemia
Investigated drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies